SAFC wins preformulation services deal

- Last updated on GMT

SAFC gets preformulation deal
SAFC gets preformulation deal
SAFC will provide pre-formulation services for South Korea-based NSAID developer CrystalGenomics.

Under the deal – financial terms of which have not been disclosed – the custom manufacturing firm will use its pre-formulation laboratory in Cambridge, UK to assess the physical properties of CrystalGenomics' candidate compounds.

SAFC president Gilles Cottier said: "Our expertise in the pre-formulation of pharmaceuticals has allowed us to engage with CrystalGenomics through this agreement and to introduce our unique technologies to the South Korea market.

"As the drug discovery and development process becomes increasingly complex and expensive, we feel that our pre-formulation services are well-positioned to help pharmaceutical and biopharmaceutical companies around the globe to accelerate their pipelines."

Related topics: Commercial Services

Related news

Show more